Fairvalue-Calculator Fairvalue-Calculator
EN DE

Jilin Jian Yisheng Pharmaceutical Co (002566) Fair Value & Analysis

Healthcare · CN · Market cap 2.2B CNY

Price¥6.48
Fair Value¥1.93
Upside-70.2%
Quality90/100
Evidence: High Range ¥1.45 – ¥2.41

Fair value as of: Jun 25, 2026

Analysis

Jilin Jian Yisheng Pharmaceutical Co (002566) currently trades at ¥6.48, while our model-based Fair Value estimate is ¥1.93 — implying the stock looks roughly 70.2% overvalued today. We read business quality at 90/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Jilin Jian Yisheng Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China. The company offers paper packaging products; drugs comprising capsules, injections, tablets, granules, and other drug products; cosmetics; ginseng products; bee products; and food products comprising acai collagen solid drinks, multivitamin mineral tablets, collagen peptide juice drinks, and fruit lemon powder. It is also involved in pharmaceutical contract manufacturing; production of health food, food, health care products, special medicine purpose formula, fertilizers, beverages, and Chinese herbal medicine extracts; sale of food through the Internet; planting of Chinese herbal medicine extracts; wholesale and retail of cosmetics; road freight transportation; research and development of biological organic; non-residential real estate, machinery, and equipment leasing; packaging pri…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Jilin Jian Yisheng Pharmaceutical Co (002566) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥1.93 versus a price of ¥6.48 — about −70% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 002566?
Our 21-model fair value for Jilin Jian Yisheng Pharmaceutical Co is ¥1.93 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥6.48.
What is the quality score of 002566?
Jilin Jian Yisheng Pharmaceutical Co has a Quality Score of 90/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.